Both in Pharmaceuticals
MBX Biosciences vs NewAmsterdam Pharma Company N.V
Over the past year MBX returned +221.9% and NAMS returned −13.5%; their daily moves had a correlation of 0.34.
MBX +221.9% NAMS −13.5%Growth of $1, one year, split-adjusted
| Metric | MBX | NAMS |
|---|---|---|
| Price | $57.75 | $23.81 |
| Market cap | $2.78B | $2.85B |
| Today | +0.36% | +0.98% |
| 1 month | −8.3% | −8.1% |
| 6 months | +114.5% | −18.8% |
| Year to date | +83.1% | −32.1% |
| 1 year | +229.8% | −16.5% |
| Revenue growth (YoY) | — | −80.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −1732.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 399.7× |
| Net cash | — | $633.9M |
| Dividend yield | — | — |
| Volatility (60d) | 60.5% | 53.2% |
| Short % of float | 14.0% | 23.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).